MediWound (MDWD) Share-based Compensation (IS) (2013 - 2025)
MediWound (MDWD) recorded quarterly Share-based Compensation (IS) of $740000.0 in Q3 2025, down 14.15% quarter-over-quarter from $862000.0 in Q2 2025, and down 29.25% on a YoY basis from $1.0 million in Q3 2024.
MediWound (MDWD) Share-based Compensation (IS) (2013 - 2025) Analysis & Trends
MediWound's Share-based Compensation (IS) history runs 13 years deep, the most recent figure standing at $740000.0 for Q3 2025.
- In Q3 2025, Share-based Compensation (IS) fell 29.25% year-over-year to $740000.0; the TTM figure through Sep 2025 stood at $3.3 million (up 25.02% YoY), while the FY2024 annual figure was $3.1 million, up 61.75% from the prior year.
- Share-based Compensation (IS) was $740000.0 for Q3 2025 at MediWound, down from $862000.0 in the prior quarter.
- In the past five years, Share-based Compensation (IS) ranged from a high of $1.0 million in Q3 2024 to a low of $252000.0 in Q2 2022.
- Historically, Share-based Compensation (IS) has averaged $586473.7 across 5 years, with a median of $619000.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation (IS) sank 56.01% in 2023, then surged 236.33% in 2024.
- A 5-year view of Share-based Compensation (IS) shows it stood at $390000.0 in 2021, then soared by 64.62% to $642000.0 in 2022, then tumbled by 53.58% to $298000.0 in 2023, then soared by 175.84% to $822000.0 in 2024, then declined by 9.98% to $740000.0 in 2025.
- The last three Share-based Compensation (IS) figures came in at $740000.0 (Q3 2025), $862000.0 (Q2 2025), and $844000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.45 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 892,057.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 14.90 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 740,000.00 |
| Sep 30, 2025 | 740,000.00 |
| Jun 30, 2025 | 862,000.00 |
| Jun 30, 2025 | 862,000.00 |
| Mar 31, 2025 | 844,000.00 |
| Mar 31, 2025 | 844,000.00 |
| Dec 31, 2024 | 822,000.00 |
| Dec 31, 2024 | 822,000.00 |
| Sep 30, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 758,000.00 |
| Jun 30, 2024 | 758,000.00 |
| Mar 31, 2024 | 512,000.00 |
| Mar 31, 2024 | 512,000.00 |
| Dec 31, 2023 | 298,000.00 |
| Dec 31, 2023 | 298,000.00 |
| Sep 30, 2023 | 311,000.00 |
| Sep 30, 2023 | 311,000.00 |
| Jun 30, 2023 | 712,000.00 |
| Jun 30, 2023 | 712,000.00 |